Xvivo Perfusion AB (XVIPF)
22.81
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Xvivo Perfusion EPS Diluted (Quarterly) : 0.1258 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Elekta AB | 0.0028 |
| Getinge AB | 0.1611 |
| Arjo AB | 0.0434 |
| Paxman AB | -0.04 |
| Immunovia AB | -0.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.971M |
| Revenue (Quarterly) | 26.36M |
| Total Expenses (Quarterly) | 22.39M |
| Enterprise Value | 699.06M |
| Gross Profit Margin (Quarterly) | 63.69% |
| Profit Margin (Quarterly) | 15.06% |
| Earnings Yield | 1.11% |
| Operating Earnings Yield | 1.38% |
| Normalized Earnings Yield | 1.099 |